Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)
Summary
The notice announces a renewal of the NIH Research Evaluation and Commercialization Hub (REACH) program to fund academic entrepreneurship hubs that will help translate biomedical discoveries into products. The program provides seed funding, mentorship, and resources for early‑stage technology development and commercialization, aiming to accelerate patient‑care innovations.